Copyright Reports & Markets. All rights reserved.

Global Artificial Intelligence in Biomedical Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Artificial Intelligence in Biomedical by Type
    • 1.3.1 Overview: Global Artificial Intelligence in Biomedical Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Artificial Intelligence in Biomedical Consumption Value Market Share by Type in 2025
    • 1.3.3 Hardware
    • 1.3.4 Software
  • 1.4 Global Artificial Intelligence in Biomedical Market by Application
    • 1.4.1 Overview: Global Artificial Intelligence in Biomedical Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Diagnosing Diseases
    • 1.4.3 Developing Drugs
    • 1.4.4 Personalized Treatment
    • 1.4.5 Other
  • 1.5 Global Artificial Intelligence in Biomedical Market Size & Forecast
  • 1.6 Global Artificial Intelligence in Biomedical Market Size and Forecast by Region
    • 1.6.1 Global Artificial Intelligence in Biomedical Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Artificial Intelligence in Biomedical Market Size by Region, (2021-2032)
    • 1.6.3 North America Artificial Intelligence in Biomedical Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Artificial Intelligence in Biomedical Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Artificial Intelligence in Biomedical Market Size and Prospect (2021-2032)
    • 1.6.6 South America Artificial Intelligence in Biomedical Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Artificial Intelligence in Biomedical Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca Artificial Intelligence in Biomedical Product and Solutions
    • 2.1.4 AstraZeneca Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AstraZeneca Recent Developments and Future Plans
  • 2.2 Thales Group
    • 2.2.1 Thales Group Details
    • 2.2.2 Thales Group Major Business
    • 2.2.3 Thales Group Artificial Intelligence in Biomedical Product and Solutions
    • 2.2.4 Thales Group Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Thales Group Recent Developments and Future Plans
  • 2.3 IBM Corp.
    • 2.3.1 IBM Corp. Details
    • 2.3.2 IBM Corp. Major Business
    • 2.3.3 IBM Corp. Artificial Intelligence in Biomedical Product and Solutions
    • 2.3.4 IBM Corp. Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 IBM Corp. Recent Developments and Future Plans
  • 2.4 ForeSee Medical
    • 2.4.1 ForeSee Medical Details
    • 2.4.2 ForeSee Medical Major Business
    • 2.4.3 ForeSee Medical Artificial Intelligence in Biomedical Product and Solutions
    • 2.4.4 ForeSee Medical Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ForeSee Medical Recent Developments and Future Plans
  • 2.5 Atomwise
    • 2.5.1 Atomwise Details
    • 2.5.2 Atomwise Major Business
    • 2.5.3 Atomwise Artificial Intelligence in Biomedical Product and Solutions
    • 2.5.4 Atomwise Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Atomwise Recent Developments and Future Plans
  • 2.6 Cloud Pharmaceuticals
    • 2.6.1 Cloud Pharmaceuticals Details
    • 2.6.2 Cloud Pharmaceuticals Major Business
    • 2.6.3 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product and Solutions
    • 2.6.4 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Cloud Pharmaceuticals Recent Developments and Future Plans
  • 2.7 GNS Healthcare
    • 2.7.1 GNS Healthcare Details
    • 2.7.2 GNS Healthcare Major Business
    • 2.7.3 GNS Healthcare Artificial Intelligence in Biomedical Product and Solutions
    • 2.7.4 GNS Healthcare Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 GNS Healthcare Recent Developments and Future Plans
  • 2.8 Microsoft Corporation
    • 2.8.1 Microsoft Corporation Details
    • 2.8.2 Microsoft Corporation Major Business
    • 2.8.3 Microsoft Corporation Artificial Intelligence in Biomedical Product and Solutions
    • 2.8.4 Microsoft Corporation Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Microsoft Corporation Recent Developments and Future Plans
  • 2.9 Novartis AG
    • 2.9.1 Novartis AG Details
    • 2.9.2 Novartis AG Major Business
    • 2.9.3 Novartis AG Artificial Intelligence in Biomedical Product and Solutions
    • 2.9.4 Novartis AG Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Novartis AG Recent Developments and Future Plans
  • 2.10 NVIDIA Corporation
    • 2.10.1 NVIDIA Corporation Details
    • 2.10.2 NVIDIA Corporation Major Business
    • 2.10.3 NVIDIA Corporation Artificial Intelligence in Biomedical Product and Solutions
    • 2.10.4 NVIDIA Corporation Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 NVIDIA Corporation Recent Developments and Future Plans
  • 2.11 Pfizer
    • 2.11.1 Pfizer Details
    • 2.11.2 Pfizer Major Business
    • 2.11.3 Pfizer Artificial Intelligence in Biomedical Product and Solutions
    • 2.11.4 Pfizer Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Pfizer Recent Developments and Future Plans
  • 2.12 Recursion Pharmaceuticals
    • 2.12.1 Recursion Pharmaceuticals Details
    • 2.12.2 Recursion Pharmaceuticals Major Business
    • 2.12.3 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product and Solutions
    • 2.12.4 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Recursion Pharmaceuticals Recent Developments and Future Plans
  • 2.13 XtalPi Inc
    • 2.13.1 XtalPi Inc Details
    • 2.13.2 XtalPi Inc Major Business
    • 2.13.3 XtalPi Inc Artificial Intelligence in Biomedical Product and Solutions
    • 2.13.4 XtalPi Inc Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 XtalPi Inc Recent Developments and Future Plans
  • 2.14 Aidoc
    • 2.14.1 Aidoc Details
    • 2.14.2 Aidoc Major Business
    • 2.14.3 Aidoc Artificial Intelligence in Biomedical Product and Solutions
    • 2.14.4 Aidoc Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Aidoc Recent Developments and Future Plans
  • 2.15 AliveCor
    • 2.15.1 AliveCor Details
    • 2.15.2 AliveCor Major Business
    • 2.15.3 AliveCor Artificial Intelligence in Biomedical Product and Solutions
    • 2.15.4 AliveCor Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 AliveCor Recent Developments and Future Plans
  • 2.16 GE Healthcare
    • 2.16.1 GE Healthcare Details
    • 2.16.2 GE Healthcare Major Business
    • 2.16.3 GE Healthcare Artificial Intelligence in Biomedical Product and Solutions
    • 2.16.4 GE Healthcare Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 GE Healthcare Recent Developments and Future Plans
  • 2.17 Imagen Technologies
    • 2.17.1 Imagen Technologies Details
    • 2.17.2 Imagen Technologies Major Business
    • 2.17.3 Imagen Technologies Artificial Intelligence in Biomedical Product and Solutions
    • 2.17.4 Imagen Technologies Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Imagen Technologies Recent Developments and Future Plans
  • 2.18 Vuno Inc.
    • 2.18.1 Vuno Inc. Details
    • 2.18.2 Vuno Inc. Major Business
    • 2.18.3 Vuno Inc. Artificial Intelligence in Biomedical Product and Solutions
    • 2.18.4 Vuno Inc. Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Vuno Inc. Recent Developments and Future Plans
  • 2.19 IDx Technologies Inc.
    • 2.19.1 IDx Technologies Inc. Details
    • 2.19.2 IDx Technologies Inc. Major Business
    • 2.19.3 IDx Technologies Inc. Artificial Intelligence in Biomedical Product and Solutions
    • 2.19.4 IDx Technologies Inc. Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 IDx Technologies Inc. Recent Developments and Future Plans
  • 2.20 Siemens Healthcare GmbH
    • 2.20.1 Siemens Healthcare GmbH Details
    • 2.20.2 Siemens Healthcare GmbH Major Business
    • 2.20.3 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product and Solutions
    • 2.20.4 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Siemens Healthcare GmbH Recent Developments and Future Plans
  • 2.21 Neural Analytics
    • 2.21.1 Neural Analytics Details
    • 2.21.2 Neural Analytics Major Business
    • 2.21.3 Neural Analytics Artificial Intelligence in Biomedical Product and Solutions
    • 2.21.4 Neural Analytics Artificial Intelligence in Biomedical Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Neural Analytics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Artificial Intelligence in Biomedical Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Artificial Intelligence in Biomedical by Company Revenue
    • 3.2.2 Top 3 Artificial Intelligence in Biomedical Players Market Share in 2025
    • 3.2.3 Top 6 Artificial Intelligence in Biomedical Players Market Share in 2025
  • 3.3 Artificial Intelligence in Biomedical Market: Overall Company Footprint Analysis
    • 3.3.1 Artificial Intelligence in Biomedical Market: Region Footprint
    • 3.3.2 Artificial Intelligence in Biomedical Market: Company Product Type Footprint
    • 3.3.3 Artificial Intelligence in Biomedical Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Artificial Intelligence in Biomedical Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Artificial Intelligence in Biomedical Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Artificial Intelligence in Biomedical Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Artificial Intelligence in Biomedical Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Artificial Intelligence in Biomedical Consumption Value by Type (2021-2032)
  • 6.2 North America Artificial Intelligence in Biomedical Market Size by Application (2021-2032)
  • 6.3 North America Artificial Intelligence in Biomedical Market Size by Country
    • 6.3.1 North America Artificial Intelligence in Biomedical Consumption Value by Country (2021-2032)
    • 6.3.2 United States Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Artificial Intelligence in Biomedical Consumption Value by Type (2021-2032)
  • 7.2 Europe Artificial Intelligence in Biomedical Consumption Value by Application (2021-2032)
  • 7.3 Europe Artificial Intelligence in Biomedical Market Size by Country
    • 7.3.1 Europe Artificial Intelligence in Biomedical Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 7.3.3 France Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Artificial Intelligence in Biomedical Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Artificial Intelligence in Biomedical Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Region
    • 8.3.1 Asia-Pacific Artificial Intelligence in Biomedical Consumption Value by Region (2021-2032)
    • 8.3.2 China Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 8.3.5 India Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Artificial Intelligence in Biomedical Consumption Value by Type (2021-2032)
  • 9.2 South America Artificial Intelligence in Biomedical Consumption Value by Application (2021-2032)
  • 9.3 South America Artificial Intelligence in Biomedical Market Size by Country
    • 9.3.1 South America Artificial Intelligence in Biomedical Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Artificial Intelligence in Biomedical Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Artificial Intelligence in Biomedical Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country
    • 10.3.1 Middle East & Africa Artificial Intelligence in Biomedical Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Artificial Intelligence in Biomedical Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Artificial Intelligence in Biomedical Market Drivers
  • 11.2 Artificial Intelligence in Biomedical Market Restraints
  • 11.3 Artificial Intelligence in Biomedical Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Artificial Intelligence in Biomedical Industry Chain
  • 12.2 Artificial Intelligence in Biomedical Upstream Analysis
  • 12.3 Artificial Intelligence in Biomedical Midstream Analysis
  • 12.4 Artificial Intelligence in Biomedical Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Artificial Intelligence in Biomedical market size was valued at US$ 258 million in 2025 and is forecast to a readjusted size of US$ 1538 million by 2032 with a CAGR of 29.4% during review period.
    Artificial Intelligence (AI) in biomedical refers to the application of AI technologies, such as machine learning, natural language processing, and computer vision, in the fields of medicine and biology. It is used to analyze complex biomedical data, assist in diagnostics, develop personalized treatment plans, discover new drugs, and improve healthcare outcomes. AI enhances the accuracy, speed, and efficiency of medical and biological research and clinical practices.
    This report is a detailed and comprehensive analysis for global Artificial Intelligence in Biomedical market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Artificial Intelligence in Biomedical market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Artificial Intelligence in Biomedical market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Artificial Intelligence in Biomedical market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Artificial Intelligence in Biomedical market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Artificial Intelligence in Biomedical
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Artificial Intelligence in Biomedical market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation, Novartis AG, NVIDIA Corporation, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Artificial Intelligence in Biomedical market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Hardware
    Software
    Market segment by Application
    Diagnosing Diseases
    Developing Drugs
    Personalized Treatment
    Other
    Market segment by players, this report covers
    AstraZeneca
    Thales Group
    IBM Corp.
    ForeSee Medical
    Atomwise
    Cloud Pharmaceuticals
    GNS Healthcare
    Microsoft Corporation
    Novartis AG
    NVIDIA Corporation
    Pfizer
    Recursion Pharmaceuticals
    XtalPi Inc
    Aidoc
    AliveCor
    GE Healthcare
    Imagen Technologies
    Vuno Inc.
    IDx Technologies Inc.
    Siemens Healthcare GmbH
    Neural Analytics
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Artificial Intelligence in Biomedical product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Artificial Intelligence in Biomedical, with revenue, gross margin, and global market share of Artificial Intelligence in Biomedical from 2021 to 2026.
    Chapter 3, the Artificial Intelligence in Biomedical competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Artificial Intelligence in Biomedical market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence in Biomedical.
    Chapter 13, to describe Artificial Intelligence in Biomedical research findings and conclusion.

    Buy now